Anti-IL-5 treatments are a useful adjunct for treatment of chronic severe asthma

J Paediatr Child Health. 2024 Oct;60(10):613-615. doi: 10.1111/jpc.16639. Epub 2024 Sep 3.

Authors

Gillian M Nixon^{1

2}, David G McNamara³, David S Armstrong^{1

2}

Affiliations

¹ Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
² Department of Respiratory and Sleep Medicine, Monash Children's Hospital, Melbourne, Victoria, Australia.
³ Paediatric Respiratory and Sleep Medicine Department, Starship Children's Hospital, Auckland, New Zealand.

PMID: 39225129
DOI: 10.1111/jpc.16639

No abstract available

MeSH terms

Anti-Asthmatic Agents / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma* / drug therapy
Chronic Disease
Humans
Interleukin-5* / antagonists & inhibitors
Review Literature as Topic

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Interleukin-5